Literature DB >> 19687176

The five-year evolution of a mixed psychiatric and somatic care unit: a European experience.

Christel Alberque1, Marianne Gex-Fabry, Barbara Whitaker-Clinch, Ariel Eytan.   

Abstract

BACKGROUND: There are virtually no reported experiences of mixed medical/psychiatry inpatient units in Europe. Such a program was created in Geneva, Switzerland, in 1999.
OBJECTIVE: The authors retrospectively analyzed clinical data from its first 5 years of operation.
METHOD: These data represent 1,380 hospitalizations. A descriptive analysis was carried out on all collected data for each year of activity.
RESULTS: The severity of physical disorders increased with time. The number of medical comorbidities, length of hospital stay, and compulsory admissions increased. The proportion of mood disorders decreased, whereas the proportion of psychotic and adjustment disorders increased.
CONCLUSION: Patients with comorbid medical and psychiatric disorders are often refused admission to both medical and psychiatric wards. Once they are admitted, they are often released prematurely or transferred to another ward too quickly because of behavioral management difficulties. Physicians who refer patients to the unit recognize the complex nature of these cases and refer them because the unit is capable of offering acute psychiatric and medical treatments and provides an environment that encourages patient cooperation and treatment adherence.

Entities:  

Mesh:

Year:  2009        PMID: 19687176     DOI: 10.1176/appi.psy.50.4.354

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  2 in total

1.  Specialized Biopsychosocial Care in Inpatient Somatic Medicine Units-A Pilot Study.

Authors:  Paul Köbler; Eva K Krauss-Köstler; Barbara Stein; Joachim H Ficker; Martin Wilhelm; Alexander Dechêne; Christiane Waller
Journal:  Front Public Health       Date:  2022-04-12

2.  Factors influencing the admission decision for Medical Psychiatry Units: A concept mapping approach.

Authors:  P J Caarls; M A van Schijndel; G van den Berk; A D Boenink; D Boerman; J G Lijmer; A Honig; M Terra; A Thijs; B Verwey; J A van Waarde; J van Wijngaarden; J J van Busschbach
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.